Čeština | Dansk | Deutsch | English | Español | Français | Italiano | Nederlands | Norsk | Polski | Português | Pусский | Suomi | Svenska | US
Euro Huntington's disease network [logo]
EHDN2018 DISEASE NETWORK REGISTRY PROJECTS LOGIN
 
 
  
Working Groups - Young Adults -
--->News
[+]The Project
[+]Locations
[-]Working Groups
--->[+]Advanced HD
--->[-]Behavioural Phenotype
--->Dates
--->[+]Meetings
--->[+]Psycho appr. & interv. Sub...
--->[+]Biological Modifiers
--->[+]Biomarkers
--->[+]Brain and Tissue Banking
--->[+]Cognitive Phenotype
--->[+]Environmental Modifiers
--->[-]Functional Ability
--->Dates
--->[+]Meetings
--->[-]Genetic Testing
--->[+]Dates
--->[+]Meetings
--->[-]Genetic Modifiers
--->[+]Dates
--->[+]Meetings
--->[-]Health Economics
--->Dates
--->[+]Meetings
--->[+]Imaging
--->[+]Juvenile HD
--->[-]Motor Phenotype
--->[+]Dates
--->[+]Meetings
--->[-]Neuroprotective Therapy
--->[+]Dates
--->[+]Meetings
--->[+]Physiotherapy
--->[-]Quality of Life
--->[+]Dates
--->[+]Meetings
--->[+]Standard of Care
--->[-]Surgical Approaches
--->Dates
--->[+]Meetings
--->[+]Symptomatic Research
--->[-]Young Adults
--->[+]Dates
--->[+]Meetings
--->Members
[-]Events
--->[+]EHDN 2018
--->[+]EHDN 2016
--->EHDN 2014
--->[-]EHDN 2012
--->Introduction
--->Announcement
--->Programme Fri
--->Programme Sat
--->Programme Sun
--->Additional Meetings
--->Important Dates
--->Registration
--->[+]Travel & Accommodation
--->[+]EHA Registration
--->EHA Programme
--->Reception Dinner
--->About Stockholm
--->[+]Abstract Submission
--->Reimbursement
--->[+]Documents
--->Contacts
--->Feedback & Evaluation
--->[-]EHDN 2010
--->Introduction
--->Programme I
--->Programme II
--->Additional Meetings
--->Registration
--->EHA Programme
--->[-]EHA Registration
--->Plenary Dinner
--->Social Programme
--->Important Dates
--->[+]Abstract Submission
--->Reimbursement
--->Hotel Booking
--->[+]Travel and Location
--->[-]About Prague
--->Cultural Entertainment
--->Sightseeing
--->Food & Drink
--->Documents
--->Committees
--->Contact
--->Feedback & Evaluation
--->[+]EHDN 2008
--->[+]EHDN 2007
--->[+]EHDN 2006
--->[+]EHDN 2005
--->[+]EHDN 2004
[+]Communication
--->Job Offers

Description

The prevalence of Huntington’s disease (HD) is about 4-10 per 100.000 with roughly 4-5 times as many – in Europe this is about 150.000 people – being at risk of developing the disease. At present we witness an increasing number of clinical trials with novel therapeutics. This gives us much hope that the treatment of those with HD will improve in the foreseeable future. The Holy Grail, however, would be something that prevented HD in someone carrying the gene. Inevitably, this will have to involve healthy individuals carrying the HD gene in clinical trials. There is therefore an increasing interest/need to study this population of individuals including the development of novel tools for clinical assessment in these future trials. Yet young adults who are ‘at-risk’, HD gene carriers or have had a negative genetic test are often overlooked in the services which are provided for people with HD,  and few young adults are currently participating in ongoing clinical studies such as REGISTRY.

At risk also means these individuals grow up in a family with HD under the Damocles’ sword of having, or not, inherited the HD gene mutation. Young adults with HD in the family often feel ‘alone in the midst of others’ (Sharpel et al 2008); while they have friends, they describe them as being unable to really understand what it’s like to live with HD. This population needs genetic counselling, advice on important life decisions and treatment of medical conditions. We know too little about other needs. Better knowledge may inform best clinical practice and a standard set up of a clinic dedicated to these individuals. Support networks for young adults are missing in many countries.  The YAWG itself will not form a support group, but would aim to enable young adults to create support networks in the countries they represent

Survey for young adults in HD families

English Version:
Click here to take survey

Spanish Version
Click here to take survey

German Version
Click here to take survey

Dutch Version
Click here to take survey

Danish Version
Click here to take survey

Swedish Version
Click here to take survey

Italian Version
Click here to take survey

French Version
Click here to take survey

Polish Version
Click here to take survey

Norwegian Version
Click here to take survey
David Drain
YAWG Chair, Lead Facilitator
Clinical Genetics Centre Scottish HD Assoc., Ashgrove House
Postal address: Foresterhill Hospital
AB25 2ZA Aberdeen
U.K.
phone: +44 1224 550063
e-mail: 
 
Dr. Michael Orth
Principal Investigator, Coordination DE AT CH
Ulm University Hospital, Neurology
Postal address: Oberer Eselsberg 45/1
89081 Ulm
Deutschland
phone: +49 731 50063095
fax: +49 731 50063082
e-mail: 
Saül Martinez-Horta
Lead Falitator, Co-Investigadtor, Neurology, Neuropsychologist
Hospital de la Santa Creu i Sant Pau
Postal address: C/Mas de Casanovas 90
08041 Barcelona
Barcelona
phone: +34 93 556 55 19 (Ext.5519)
e-mail: 
Jaime Levey
Central Coordination, Lead Facilitator
Postal address: 17, Rue Monge
75005 Paris
France
phone: +33682557601
e-mail: 

Associated Language Area Coordinator (Lanco)

Andrea Horta, Spain
YAWG Chair Peter Carruthers
Specialist Youth Advisor, Lead Facilitator, Scottish HD Association
Whytemans Brae Hospital
Postal address: Kirkcaldy, Fife, KY1 2ND

Scotland
phone: 07538951425
e-mail: 
homepage: www.hdscotland.org
about us | privacy statement | disclaimer | terms of use